drug development - search results

Diabetes can pose significant implications for individuals’ mental and physical wellbeing. While new research shows promise in supporting diabetes management and care, many challenges still remain. We discussed these with Beyond Type 1’s content strategist Dr Liz Kopco.

The promise of connected care has expanded the opportunities for how clinicians and patients interact, offering care from a distance and creating a shift towards more accessible systems.

Professor Channakeshava S Umeshappa from Dalhousie University discusses the burden of primary biliary cholangitis and how understanding immune mechanisms may help to treat it.

Stephen Kry, Professor from the University of Texas MD Anderson Cancer Center, explores clinical trial challenges for new technology in radiation oncology, including the radiotherapy treatment technique, proton therapy.

Tadeusz Hawrot, Founder and Executive Director of PAREA, states the case for a new focus in the EU’s mental health care approach, that is the underserved area of psychedelic therapies.

CorTec’s Brain Interchange™ system offers closed-loop neuromodulation, revolutionizing brain therapy by precisely adapting treatment based on individual needs.

Mary Cannon, Professor of Psychiatric Epidemiology and Youth Mental Health at RCSI University of Medicine and Health Sciences, investigates the effects of using cannabis on young people’s mental health.

Norm Buckley and Jason Busse from the Michael G. DeGroote Institute for Pain Research & Care in Canada probe the effectiveness of opioid use in Canada as a treatment for chronic noncancer pain.

CIE Smith, MD, PhD, Professor, Dept of Laboratory Medicine, Karolinska Institutet (KI) CIE Smith is professor in molecular genetics at Karolinska Institutet. Smith’s main research interest is cellular signaling, especially protein phosphorylation in lymphocyte development and synthetic oligonucleotide therapies His research group cloned the disease gene, BTK, for X-linked agammaglobulinemia...

Dr Woori Jo is a senior researcher and administrator in Preclinical Research Centre at K-MEDI hub She is and adjunct professor at the college of veterinary medicine in Kyungpook National University. She manages the sanitation and environment of laboratory animals and makes efforts to improve animal welfare at Preclinical Research...

Dr KilSoo Kim is a director of Preclinical Research Centre at K-MEDI hub and a professor of toxicology at the college of veterinary medicine in Kyungpook National University He manages all the work for Preclinical Research Centre at K-MEDI hub. He is increasing the success rate of commercialization in the...

Photodynamic therapy, using visible light with lower energy, causes fewer side effects when treating cancer, find Drs. Mary Potasek, Evgueni Parilov, and Karl Beeson, Co-founders of Simphotek, Inc.

Innovation for new healthcare technology has been funded toward treatments for Alzheimer’s, cancer and more, with support going to digital hubs and technology-assisted surgery.

JoAnne S Richards, PhD, Professor at Baylor College of Medicine, explores ovarian cancer research with a focus on ovarian function and dysfunction.

Blockchain wasn’t invented as a supply management tool; yet, today it is helping to solve some of the most complex problems existing in global supply chains.

Laneshia Conner, Assistant Professor at the University of Kentucky, discusses gaps in HIV and AIDS prevention and why greater awareness and support for HIV risk in older adults is needed.

Maria Adebowale-Schwarte, CEO of Foundation for Future London, analyses and promotes sustainable and equitable futures through placemaking.

Monica Racoviță, Senior Researcher at The Health Policy Partnership, argues that opioid dependence is a pressing issue, yet treatment for it is still out of reach for many.

A recent study published in the British Journal of Pharmacology has shed light on the association between excessive salt consumption and cognitive impairment resulting from hypertension.

Amidst the rising spread of antimicrobial resistance, hope emerges in the form of a ground-breaking tool. Progress in gene editing holds the potential to curb the relentless march of antimicrobial resistance.